Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Vascular Surgery

Free Subscription Articles published in Circulation Retrieve available abstracts of 95 articles: HTML format

Single Articles

July 2022
1. KRAWISZ AK, Natesan S, Wadhera RK, Chen S, et al
   Differences in Comorbidities Explain Black-White Disparities in Outcomes After Femoropopliteal Endovascular Intervention.
   Circulation. 2022;146:191-200.
   PubMed     Abstract available
   
   
   
2. HANKEY GJ
   Endovascular Therapy for Acute Basilar Artery Occlusion.
   Circulation. 2022;146:18-20.
   PubMed    
   
   
   June 2022
3. ABDELHALIM MA, Patel A, Moquet J, Saha P, et al
   Higher Incidence of Chromosomal Aberrations in Operators Performing a Large Volume of Endovascular Procedures.
   Circulation. 2022;145:1808-1810.
   PubMed    
   
   
   
4. TAO C, Qureshi AI, Yin Y, Li J, et al
   Endovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry.
   Circulation. 2022 Jun 3:101161CIRCULATIONAHA121058544.
   PubMed     Abstract available
   
   
   May 2022
5. SHISHEHBOR MH, Zeller T, Werner M, Brodmann M, et al
   Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study).
   Circulation. 2022;145:1645-1654.
   PubMed     Abstract available
   
   
   
6. FEARON WF, Zimmermann FM, Ding VY, Zelis JM, et al
   Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery.
   Circulation. 2022;145:1655-1662.
   PubMed     Abstract available
   
   
   April 2022
7. PATEL KK
   Improving Symptoms and Quality of Life in Stable Coronary Artery Disease: An Evolving Paradigm.
   Circulation. 2022;145:1308-1311.
   PubMed    
   
   
   
8. LUSEBRINK E, Kellnar A, Krieg K, Binzenhofer L, et al
   Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.
   Circulation. 2022;145:1254-1284.
   PubMed     Abstract available
   
   
   
9. WHITE HD
   Zooming in on the Enigmas of Type 2 Myocardial Infarction.
   Circulation. 2022;145:1201-1204.
   PubMed    
   
   
   
10. SEIKE Y, Matsuda H, Shimizu H, Ishimaru S, et al
    Nationwide Analysis of Persistent Type II Endoleak and Late Outcomes of Endovascular Abdominal Aortic Aneurysm Repair in Japan: A Propensity-Matched Analysis.
    Circulation. 2022;145:1056-1066.
    PubMed     Abstract available
    
    
    March 2022
11. JOUNDI RA, Sun JL, Xian Y, Alhanti B, et al
    Association Between Endovascular Therapy Time to Treatment and Outcomes in Patients With Basilar Artery Occlusion.
    Circulation. 2022;145:896-905.
    PubMed     Abstract available
    
    
    
12. MAAMARI DJ, Jaffer FA, Khera AV, Fahed AC, et al
    CYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine?
    Circulation. 2022;145:721-723.
    PubMed    
    
    
    February 2022
13. DASHWOOD MR, Pinheiro BB, Souza DSR
    Thirty Years of No-Touch Saphenous Vein Harvesting: A Timely Jubilee Gift.
    Circulation. 2022;145:319-320.
    PubMed    
    
    
    January 2022
14. CHEW DS, Cowper PA, Al-Khalidi H, Anstrom KJ, et al
    Cost Effectiveness of Coronary-Artery Bypass Surgery versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial.
    Circulation. 2022 Jan 19. doi: 10.1161/CIRCULATIONAHA.121.056276.
    PubMed     Abstract available
    
    
    
15. GRUBB KJ, Kirtane AJ
    The Long-Awaited Revascularization Guidelines Are Out: What's In Them?
    Circulation. 2022;145:155-157.
    PubMed    
    
    
    December 2021
16. LAM CZ, Gulamhusein A, Wald RM
    Liver Cirrhosis and Hepatocellular Carcinoma After the Fontan Operation: Reaching Clarity in the Face of Uncertainty.
    Circulation. 2021;144:1977-1980.
    PubMed    
    
    
    
17. NII M, Inuzuka R, Inai K, Shimada E, et al
    Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation.
    Circulation. 2021;144:2043-2045.
    PubMed    
    
    
    
18. LAWTON JS, Tamis-Holland JE, Bangalore S, Bates ER, et al
    2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2021 Dec 9:CIR0000000000001039. doi: 10.1161/CIR.0000000000001039.
    PubMed     Abstract available
    
    
    October 2021
19. VERMA S, Bhatt DL, Steg PG, Miller M, et al
    Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.056290.
    PubMed     Abstract available
    
    
    
20. DAHLE G, Kempfert J
    Fifty Years After the Introduction of Vein Grafts for CABG: New Evidence for a No-Touch Harvesting Approach.
    Circulation. 2021;144:1130-1132.
    PubMed    
    
    
    
21. GAUDINO M, Sandner S, Di Giammarco G, Di Franco A, et al
    The Use of Intraoperative Transit Time Flow Measurement for Coronary Artery Bypass Surgery: Systematic Review of the Evidence and Expert Opinion Statements.
    Circulation. 2021;144:1160-1171.
    PubMed     Abstract available
    
    
    September 2021
22. EDGAR L, Akbar N, Braithwaite AT, Krausgruber T, et al
    Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis.
    Circulation. 2021;144:961-982.
    PubMed     Abstract available
    
    
    
23. TIAN M, Wang X, Sun H, Feng W, et al
    No-Touch Versus Conventional Vein Harvesting Techniques at 12 Months After Coronary Artery Bypass Grafting Surgery: Multicenter Randomized, Controlled Trial.
    Circulation. 2021 Sep 13. doi: 10.1161/CIRCULATIONAHA.121.055525.
    PubMed    
    
    
    
24. KIM MS, Kim KB
    Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft: Ten-Year Angiographic and Long-Term Clinical Results of the SAVE RITA Trial.
    Circulation. 2021 Sep 8. doi: 10.1161/CIRCULATIONAHA.121.056438.
    PubMed    
    
    
    August 2021
25. XENOGIANNIS I, Zenati M, Bhatt DL, Rao SV, et al
    Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies.
    Circulation. 2021;144:728-745.
    PubMed     Abstract available
    
    
    
26. WATERS DD, Stone GW
    Usefulness of Angina to Guide Revascularization Decisions.
    Circulation. 2021;144:524-527.
    PubMed    
    
    
    July 2021
27. MEHTA SR
    Achieving Complete Revascularization for Multivessel Coronary Artery Disease.
    Circulation. 2021;144:110-112.
    PubMed    
    
    
    June 2021
28. DECANO JL, Singh SA, Gasparotto Bueno C, Ho Lee L, et al
    Systems Approach to Discovery of Therapeutic Targets for Vein Graft Disease: PPARalpha Pivotally Regulates Metabolism, Activation, and Heterogeneity of Macrophages and Lesion Development.
    Circulation. 2021;143:2454-2470.
    PubMed     Abstract available
    
    
    May 2021
29. TAKAHASHI K, Serruys PW, Gao C, Ono M, et al
    Ten-Year All-Cause Death According to Completeness of Revascularization in Patients with Three-Vessel Disease or Left Main Coronary Artery Disease: Insights from the SYNTAX Extended Survival Study.
    Circulation. 2021 May 20. doi: 10.1161/CIRCULATIONAHA.120.046289.
    PubMed     Abstract available
    
    
    April 2021
30. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
    Randomized Clinical Comparison of the Dual Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent with the Sirolimus-Eluting Orsiro Stent in Patients Treated with Percutaneous Coronary Intervention: The SORT OUT X Trial.
    Circulation. 2021 Apr 7. doi: 10.1161/CIRCULATIONAHA.120.052766.
    PubMed     Abstract available
    
    
    
31. SHAH R
    Letter by Shah Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
    Circulation. 2021;143:e807-e808.
    PubMed    
    
    
    March 2021
32. VERRALL CE, Yang JYM, Chen J, Schembri A, et al
    Neurocognitive Dysfunction and Smaller Brain Volumes in Adolescents and Adults With a Fontan Circulation.
    Circulation. 2021;143:878-891.
    PubMed     Abstract available
    
    
    February 2021
33. ANGIOLILLO DJ, Bhatt DL, Cannon CP, Eikelboom JW, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
    Circulation. 2021;143:583-596.
    PubMed     Abstract available
    
    
    January 2021
34. HIJAZI Z, Alexander JH, Li Z, Wojdyla DM, et al
    Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients with Atrial Fibrillation After Acute Coronary Syndrome or PCI: Insights from The AUGUSTUS Trial.
    Circulation. 2021 Jan 19. doi: 10.1161/CIRCULATIONAHA.120.051020.
    PubMed     Abstract available
    
    
    
35. O'FEE K, Panza JA, Brown DL
    Association of Inducible Myocardial Ischemia With Long-Term Mortality and Benefit From Coronary Artery Bypass Graft Surgery in Ischemic Cardiomyopathy: Ten-Year Follow-Up of the STICH Trial.
    Circulation. 2021;143:205-207.
    PubMed    
    
    
    December 2020
36. PAL N, Padala S, Klein K
    Letter by Pal et al Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e501-e502.
    PubMed    
    
    
    
37. BELLEY-COTE EP, Whitlock RP
    Letter by Belley-Cote and Whitlock Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e503.
    PubMed    
    
    
    
38. MAHMOOD E, Sharkey A, Matyal R, Mahmood F, et al
    Response by Mahmood et al to Letter Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e504-e505.
    PubMed    
    
    
    
39. IGLESIAS JF, Valgimigli M, Carbone F, Lauriers N, et al
    Effects of Fentanyl Versus Morphine on Ticagrelor-Induced Platelet Inhibition in Patients With ST-Segment Elevation Myocardial Infarction: The PERSEUS Randomized Trial.
    Circulation. 2020;142:2479-2481.
    PubMed    
    
    
    
40. VLACHOJANNIS GJ, Wilschut JM, Vogel RF, Lemmert ME, et al
    Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial.
    Circulation. 2020;142:2316-2328.
    PubMed     Abstract available
    
    
    
41. SOGAARD M, Nielsen PB, Skjoth F, Eldrup N, et al
    Temporal Changes in Secondary Prevention and Cardiovascular Outcomes after Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.
    Circulation. 2020 Dec 10. doi: 10.1161/CIRCULATIONAHA.120.047994.
    PubMed     Abstract available
    
    
    
42. CHAITMAN BR, Alexander KP, Cyr DD, Berger JS, et al
    Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
    Circulation. 2020 Dec 3. doi: 10.1161/CIRCULATIONAHA.120.047987.
    PubMed     Abstract available
    
    
    November 2020
43. KIM HS, Kang J, Hwang D, Han JK, et al
    Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS Trial.
    Circulation. 2020 Nov 18. doi: 10.1161/CIRCULATIONAHA.120.051700.
    PubMed     Abstract available
    
    
    
44. ALEXANDER JH, Smith PK
    Are We At Risk of Depriving Patients Lifesaving Cardiac Surgery?: Implications of the ISCHEMIA Trial for Coronary Artery Bypass Graft Surgery.
    Circulation. 2020;142:1797-1798.
    PubMed    
    
    
    October 2020
45. AYTEKIN A, Ndrepepa G, Neumann FJ, Menichelli M, et al
    Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Circulation. 2020 Oct 29. doi: 10.1161/CIRCULATIONAHA.120.050244.
    PubMed     Abstract available
    
    
    
46. FRANCHI F, Rollini F, Been L, Briceno M, et al
    Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention
    Circulation. 2020;142:1500-1502.
    PubMed    
    
    
    
47. BENEDETTO U, Gaudino MF, Dimagli A, Gerry S, et al
    Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020;142:1320-1329.
    PubMed     Abstract available
    
    
    
48. DUNN AN, Donnellan E, Johnston DR, Alashi A, et al
    Long-Term Outcomes of Patients With Mediastinal Radiation-Associated Coronary Artery Disease Undergoing Coronary Revascularization With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting.
    Circulation. 2020;142:1399-1401.
    PubMed    
    
    
    
49. LYTLE B, Gaudino M
    Fractional Flow Reserve for Coronary Artery Bypass Surgery.
    Circulation. 2020;142:1315-1316.
    PubMed    
    
    
    August 2020
50. KHALID N, Shlofmitz E, Waksman R
    Letter by Khalid et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e76-e77.
    PubMed    
    
    
    
51. VINCENT F, Van Belle E, Susen S
    Letter by Vincent et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e80-e81.
    PubMed    
    
    
    
52. O'NEILL WW, Burkhoff D
    Letter by O'Neill and Burkhoff Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e78-e79.
    PubMed    
    
    
    
53. HELGESTAD OKL, Moller S, Moller JE
    Letter by Helgestad et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e72-e73.
    PubMed    
    
    
    
54. AMIN AP, Rao SV, Bach RG, Curtis JP, et al
    Response by Amin et al to Letters Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e82-e84.
    PubMed    
    
    
    
55. CHIEFFO A, Gramegna M, Pappalardo F
    Letter by Chieffo et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e74-e75.
    PubMed    
    
    
    
56. GARGIULO G, Esposito G, Avvedimento M, Nagler M, et al
    Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial.
    Circulation. 2020;142:441-454.
    PubMed     Abstract available
    
    
    
57. KHAN SU, Singh M, Valavoor S, Khan MU, et al
    Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis.
    Circulation. 2020 Aug 3. doi: 10.1161/CIRCULATIONAHA.120.046308.
    PubMed     Abstract available
    
    
    July 2020
58. FARIDI KF, Tamez H, Strom JB, Song Y, et al
    Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.
    Circulation. 2020;142:306-308.
    PubMed    
    
    
    June 2020
59. COLLERAN R, Byrne RA
    Polymer-Free Drug-Eluting Stents: The Importance of the Right Control.
    Circulation. 2020;141:2064-2066.
    PubMed    
    
    
    
60. O'DONOGHUE ML, Murphy SA, Sabatine MS
    The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y12 Inhibitor in Patients after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Circulation. 2020 Jun 19. doi: 10.1161/CIRCULATIONAHA.120.046251.
    PubMed     Abstract available
    
    
    
61. ROFFI M, Guagliumi G, Ibanez B
    The Obstacle Course of Reperfusion for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic.
    Circulation. 2020;141:1951-1953.
    PubMed    
    
    
    
62. DANIELS MJ, Cohen MG, Bavry AA, Kumbhani DJ, et al
    Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?
    Circulation. 2020;141:1948-1950.
    PubMed    
    
    
    
63. CHANDRASHEKHAR Y, Alexander T, Mullasari A, Kumbhani DJ, et al
    Resource and Infrastructure-Appropriate Management of ST-Segment Elevation Myocardial Infarction in Low- and Middle-Income Countries.
    Circulation. 2020;141:2004-2025.
    PubMed     Abstract available
    
    
    
64. MAHMOOD E, Matyal R, Mahmood F, Xu X, et al
    Impact of Left Atrial Appendage Exclusion on Short Term Outcomes In Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020 Jun 3. doi: 10.1161/CIRCULATIONAHA.119.044642.
    PubMed     Abstract available
    
    
    May 2020
65. NAVARESE EP, Khan SU, Kolodziejczak M, Kubica J, et al
    Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52,816 Patients from 12 Randomized Trials.
    Circulation. 2020 May 29. doi: 10.1161/CIRCULATIONAHA.120.046786.
    PubMed     Abstract available
    
    
    
66. JENSEN LO, Maeng M, Raungaard B, Kahlert J, et al
    Randomised Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent with the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated with Percutaneous Coronary Intervention: The SORT OUT IX Trial
    Circulation. 2020 May 21. doi: 10.1161/CIRCULATIONAHA.119.040241.
    PubMed     Abstract available
    
    
    April 2020
67. PICCOLO R, Bruzzese D, Mauro C, Aloia A, et al
    Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated with the COVID-19 Outbreak.
    Circulation. 2020 Apr 30. doi: 10.1161/CIRCULATIONAHA.120.047457.
    PubMed    
    
    
    
68. ZHOU X, Li Y, Yang Q
    Antiplatelet Therapy Following Percutaneous Coronary Intervention in Patients Complicated by COVID-19: Implications from Clinical Features to Pathological Findings.
    Circulation. 2020 Apr 16. doi: 10.1161/CIRCULATIONAHA.120.046988.
    PubMed    
    
    
    March 2020
69. PARK DW, Ahn JM, Park H, Yun SC, et al
    Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.
    Circulation. 2020 Mar 30. doi: 10.1161/CIRCULATIONAHA.120.046039.
    PubMed    
    
    
    
70. ALFONSO F, Kastrati A
    Ten-Year Follow-Up of Left Main Coronary Artery Revascularization: Still Equipoise Between Percutaneous Interventions and Surgery?
    Circulation. 2020 Mar 30. doi: 10.1161/CIRCULATIONAHA.120.046154.
    PubMed    
    
    
    
71. ALEXANDER JH, Wojdyla D, Vora AN, Thomas L, et al
    The Risk / Benefit Tradeoff of Antithrombotic Therapy in Patients with Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046534.
    PubMed     Abstract available
    
    
    
72. SORRENTINO S, Claessen BE, Chandiramani R, Guedeney P, et al
    Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
    Circulation. 2020;141:891-901.
    PubMed     Abstract available
    
    
    
73. WANKEN ZJ, Trooboff SW, Gladders B, Columbo JA, et al
    Characterization of Endovascular Abdominal Aortic Aneurysm Repair Surveillance in the Vascular Quality Initiative.
    Circulation. 2020;141:866-868.
    PubMed    
    
    
    February 2020
74. GEWILLIG M, van de Bruaene A
    FUELing the Search for Medical Therapies in Late Fontan Failure.
    Circulation. 2020;141:652-654.
    PubMed    
    
    
    
75. GOLDBERG DJ, Zak V, Goldstein BH, Schumacher KR, et al
    Results of the FUEL Trial.
    Circulation. 2020;141:641-651.
    PubMed     Abstract available
    
    
    December 2019
76. GIUSTINO G, Leon MB, Stone GW
    Highlights of Transcatheter Cardiovascular Therapeutics 2019.
    Circulation. 2019;140:1943-1945.
    PubMed    
    
    
    November 2019
77. AMIN AP, Spertus JA, Curtis JP, Desai N, et al
    The Evolving Landscape of Impella(R) Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention with Mechanical Circulatory Support.
    Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044007.
    PubMed     Abstract available
    
    
    
78. SHAW LJ, Reynolds HR, Picard MH
    A Leap Forward for Ischemia-Guided Revascularization: Stress Echocardiography Predicts Angina Benefit With Percutaneous Coronary Intervention.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044026.
    PubMed    
    
    
    
79. AL-LAMEE RK, Shun-Shin MJ, Howard JP, Nowbar AN, et al
    Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITA.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.042918.
    PubMed    
    
    
    
80. LOPES RD, Leonardi S, Wojdyla DM, Vora AN, et al
    Stent Thrombosis in Patients with Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044584.
    PubMed     Abstract available
    
    
    October 2019
81. GODOY LC, Rao V, Farkouh ME
    Coronary Revascularization of Patients With Diabetes Mellitus in the Setting of Acute Coronary Syndromes.
    Circulation. 2019;140:1233-1235.
    PubMed    
    
    
    
82. GIRI J, Sista AK, Weinberg I, Kearon C, et al
    Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Oct 4:CIR0000000000000707. doi: 10.1161/CIR.0000000000000707.
    PubMed     Abstract available
    
    
    September 2019
83. BARON SJ, Wang K, Arnold SV, Magnuson EA, et al
    Cost-Effectiveness of Transcatheter Mitral Valve Repair versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial.
    Circulation. 2019 Sep 29. doi: 10.1161/CIRCULATIONAHA.119.043275.
    PubMed     Abstract available
    
    
    
84. WINDECKER S, Lopes RD, Massaro T, Jones-Burton C, et al
    Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial.
    Circulation. 2019 Sep 26. doi: 10.1161/CIRCULATIONAHA.119.043308.
    PubMed     Abstract available
    
    
    
85. SABATE M, Alfonso F, Cequier A, Romani S, et al
    Magnesium-Based Resorbable Scaffold versus Permanent Metallic Sirolimus-Eluting Stent in Patients with ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial.
    Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.043467.
    PubMed     Abstract available
    
    
    
86. PARK DW, Kwon O, Jang JS, Yun SC, et al
    Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial.
    Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.041766.
    PubMed    
    
    
    
87. VORA AN, Alexander JH, Wojdyla D, Aronson R, et al
    Hospitalization among Patients with Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated with Apixaban or Aspirin: Insights from the AUGUSTUS Trial.
    Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.043754.
    PubMed     Abstract available
    
    
    July 2019
88. BRILAKIS ES, Mashayekhi K, Tsuchikane E, Abi Rafeh N, et al
    Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention.
    Circulation. 2019;140:420-433.
    PubMed     Abstract available
    
    
    
89. HE Z, Ding R, Liang C
    Letter by He et al Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e156-e157.
    PubMed    
    
    
    
90. ZHU J, Peng X, Zheng Z
    Letter by Zhu et al Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e152-e153.
    PubMed    
    
    
    
91. FUERNAU G, Thiele H
    Response by Fuernau and Thiele to Letters Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e158-e159.
    PubMed    
    
    
    
92. BENGUEDDACHE S, Bendjelid K
    Letter by Bengueddache and Bendjelid Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e154-e155.
    PubMed    
    
    
    
93. SIGWART U
    Therapeutic Myocardial Infarction for Hypertrophic Obstructive Cardiomyopathy: Is It Appropriate?
    Circulation. 2019;140:11-12.
    PubMed    
    
    
    June 2019
94. STOUMPOS S, Mark PB
    Should We Ligate Arteriovenous Fistulas in Asymptomatic Patients After Kidney Transplantation?
    Circulation. 2019;139:2819-2821.
    PubMed    
    
    
    May 2019
95. PACKER M, Grayburn PA
    Contrasting Effects of Pharmacological, Procedural and Surgical Interventions on Proportionate and Disproportionate Functional Mitral Regurgitation in Chronic Heart Failure.
    Circulation. 2019 May 1. doi: 10.1161/CIRCULATIONAHA.119.039612.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: